Sandu Pharmaceuticals Limited (BOM:524703)
India flag India · Delayed Price · Currency is INR
35.00
+1.10 (3.24%)
At close: Mar 10, 2026

Sandu Pharmaceuticals Balance Sheet

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
TTM FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2020 - 2016
Cash & Equivalents
-26.5312.0622.769.3945.28
Upgrade
Short-Term Investments
---0.232.3371.28
Upgrade
Cash & Short-Term Investments
37.2126.5312.0622.9641.71116.56
Upgrade
Cash Growth
11.58%119.93%-47.45%-44.96%-64.21%656.09%
Upgrade
Accounts Receivable
-47.5748.6847.9239.9153.48
Upgrade
Other Receivables
-0.320.623.174.281.24
Upgrade
Receivables
-49.1250.3252.1345.0954.92
Upgrade
Inventory
-141.49122.51143.26112.72111.38
Upgrade
Prepaid Expenses
-1.861.150.760.871.81
Upgrade
Other Current Assets
-43.993736.3536.0820.76
Upgrade
Total Current Assets
-262.99223.04255.45236.47305.43
Upgrade
Property, Plant & Equipment
-181.22178.43169.86164.5161.06
Upgrade
Long-Term Investments
-112.74122.33115.6191.392.46
Upgrade
Other Intangible Assets
-0.240.350.510.350.68
Upgrade
Other Long-Term Assets
--00.240.140
Upgrade
Total Assets
-557.19524.15541.66492.85469.63
Upgrade
Accounts Payable
-44.8741.9583.9868.1866.7
Upgrade
Accrued Expenses
-30.3632.9829.0725.6540.88
Upgrade
Short-Term Debt
-----0.19
Upgrade
Current Portion of Leases
-0.580.03---
Upgrade
Current Income Taxes Payable
-2519.1213.2515.288.32
Upgrade
Current Unearned Revenue
-6.695.157.36.065.34
Upgrade
Other Current Liabilities
-13.367.195.243.573.76
Upgrade
Total Current Liabilities
-120.86106.41138.83118.74125.19
Upgrade
Long-Term Leases
-4.190.6---
Upgrade
Long-Term Deferred Tax Liabilities
-11.9711.2110.429.379.53
Upgrade
Other Long-Term Liabilities
------0
Upgrade
Total Liabilities
-137.02118.22149.25128.1134.72
Upgrade
Common Stock
-96.6196.6196.6188.1179.21
Upgrade
Additional Paid-In Capital
-27.5827.5827.5818.498.98
Upgrade
Retained Earnings
-190.27180.88171.95161.8144.76
Upgrade
Comprehensive Income & Other
-105.71100.8696.2796.35101.96
Upgrade
Shareholders' Equity
422.34420.17405.93392.41364.75334.91
Upgrade
Total Liabilities & Equity
-557.19524.15541.66492.85469.63
Upgrade
Total Debt
4.484.780.63--0.19
Upgrade
Net Cash (Debt)
32.7221.7611.4322.9641.71116.37
Upgrade
Net Cash Growth
16.14%90.33%-50.21%-44.96%-64.16%3823.48%
Upgrade
Net Cash Per Share
3.372.251.182.434.9116.43
Upgrade
Filing Date Shares Outstanding
9.659.669.669.668.817.92
Upgrade
Total Common Shares Outstanding
9.659.669.669.668.817.92
Upgrade
Working Capital
-142.13116.63116.62117.74180.24
Upgrade
Book Value Per Share
43.5043.4942.0240.6241.4042.28
Upgrade
Tangible Book Value
422.14419.93405.58391.91364.4334.23
Upgrade
Tangible Book Value Per Share
43.4843.4741.9840.5741.3642.20
Upgrade
Buildings
-86.1686.1685.8481.3181.31
Upgrade
Machinery
-102.6697.6181.8775.4271.83
Upgrade
Construction In Progress
---4.24.82-
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.